1
|
Wang YK, Huang XS, Sun H, Ma MD, Yu HP, Hu W, Li ZY, Li Z, Luo RH, Tian RR, Xiao TF, Yang LM, Zheng YT, Li X. Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. ACS Med Chem Lett 2024; 15:60-68. [PMID: 38229757 PMCID: PMC10789119 DOI: 10.1021/acsmedchemlett.3c00373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Revised: 12/08/2023] [Accepted: 12/09/2023] [Indexed: 01/18/2024] Open
Abstract
Bromodomain-containing protein 4 (BRD4) inhibitors have been proven to be a promising option for anti-HIV-1 latency therapeutics. We herein describe the design, synthesis, and anti-HIV-1 latency bioevaluation of triazolopyridine derivatives as BRD4 inhibitors. Among them, compound 13d displayed favorable HIV-1 reactivation and prominent safety profile without triggering abnormal immune activation. It exerted strong synergism when combined with the PKC activator prostratin and has the same BRD4-targeting latency mechanism as observed with JQ1, by stimulating Tat-dependent HIV-1 elongation. Besides, it neither affected the antiviral efficacies of antiviral drugs nor caused secondary infections to uninfected cells and the latency reversing potency of 13d, in turn, was not affected by different classes of antiviral drugs.
Collapse
Affiliation(s)
- Yan-Kai Wang
- School
of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy
of Medical Sciences, National Key Laboratory of Advanced Drug Delivery
System, Key Laboratory for Biotechnology Drugs of National Health
Commission (Shandong Academy of Medical Sciences), Key Lab for Rare
& Uncommon Diseases of Shandong Province, Jinan 250117, Shandong, China
| | - Xu-Sheng Huang
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
- University
of Chinese Academy of Sciences, Beijing 100049, China
| | - Hao Sun
- School
of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy
of Medical Sciences, National Key Laboratory of Advanced Drug Delivery
System, Key Laboratory for Biotechnology Drugs of National Health
Commission (Shandong Academy of Medical Sciences), Key Lab for Rare
& Uncommon Diseases of Shandong Province, Jinan 250117, Shandong, China
| | - Meng-Di Ma
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
- University
of Chinese Academy of Sciences, Beijing 100049, China
| | - Hai-Peng Yu
- Shandong
University, No. 72 Binhai Road, Qingdao 266237, China
| | - Wei Hu
- Shandong
University, No. 72 Binhai Road, Qingdao 266237, China
| | - Zhi-Yu Li
- Department
of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Department
of Chemistry & Biochemistry, Misher College of Arts and Sciences, University of the Sciences, 600 South 43rd Street, Philadelphia, Pennsylvania 19104, United States
| | - Zhong Li
- Shandong
University, No. 72 Binhai Road, Qingdao 266237, China
| | - Rong-Hua Luo
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
| | - Ren-Rong Tian
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
| | - Tai-Fu Xiao
- Department
of Gastrointestinal Surgery, The Second Affiliated Hospital of Kunming
Medical University, Kunming 650101, Yunnan, China
| | - Liu-Meng Yang
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
| | - Yong-Tang Zheng
- Key
Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory
of Animal Models and Human Disease Mechanisms of the Chinese Academy
of Science and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources
and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, Yunnan, China
| | - Xun Li
- School
of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy
of Medical Sciences, National Key Laboratory of Advanced Drug Delivery
System, Key Laboratory for Biotechnology Drugs of National Health
Commission (Shandong Academy of Medical Sciences), Key Lab for Rare
& Uncommon Diseases of Shandong Province, Jinan 250117, Shandong, China
| |
Collapse
|